Can S-1 replace fluorouracil for advanced gastric cancer? A PRISMA-compliant systematic review and meta-analysis

It remains to be seen whether S-1 can be a replacement for infusional fluorouracil (5-FU) for advanced gastric cancer (AGC). The aim of this study was to compare the efficacy and safety of S-1 with 5-FU in AGC. PubMed and Cochrane Library were searched. Randomized controlled trials and meta-analyses...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiao-Dong, He, Fu-Qian, Chen, Mi, Tang, Ling-Chao, Tang, Xiao-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998483/
https://www.ncbi.nlm.nih.gov/pubmed/27310997
http://dx.doi.org/10.1097/MD.0000000000003916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998483/
https://www.ncbi.nlm.nih.gov/pubmed/27310997
http://dx.doi.org/10.1097/MD.0000000000003916

Ejemplares similares